Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice. Analysis of a Swiss cohort

Publikation

Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice. Analysis of a Swiss cohort

Wissenschaftlicher Artikel/Review - 01.01.2006

Simon Dagmar, Gilgen Bobalj Nicole, Schmid-Grendelmeier Peter, Braathen Lasse R, Schöni Martin H, Anliker Mark, Laffitte Emmanuel, Weber M Monika, Wiesner Alice, Wüthrich Brunello, Lübbe Jann, Schneider Dirk

Zitation

Simon D, Gilgen Bobalj N, Schmid-Grendelmeier P, Braathen L, Schöni M, Anliker M, Laffitte E, Weber M, Wiesner A, Wüthrich B, Lübbe J, Schneider D. Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice. Analysis of a Swiss cohort. Dermatology (Basel) 2006; 213:313-8.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Dermatology (Basel) 2006; 213

Veröffentlichungsdatum

01.01.2006

ISSN (Druck)

1018-8665

Seiten

313-8

Kurzbeschreibung/Zielsetzung

Controlled studies established the efficacy and good tolerability of pimecrolimus cream 1% for the treatment of atopic dermatitis but they may not reflect real-life use.